List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 84 studies with search of: "Timolol"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Conditions: Retina;   Ocular Physiology
Interventions: Drug: latanoprost 0.005% + timolol 0,5% fixed combination;   Drug: brimonidine 0,2% + timolol 0,5% fixed combination
2 Active, not recruiting 24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG
Condition: Glaucoma
Interventions: Drug: treatment with latanoprost/timolol fixed combination;   Drug: latanoprost/timolol fixed combination drops
3 Recruiting Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Glaucoma, Open Angle;   Ocular Hypertension
Interventions: Drug: Timolol Maleate in Sorbate;   Drug: Timolol hemihydrate;   Drug: Timolol maleate gel forming solution
4 Completed A Study Demonstrating the Effect of Latanoprost in Combination With Timolol, Latanoprost Alone and Timolol Alone on Eye Pressure in Open Angle Glaucoma or Ocular Hypertension in Patients
Conditions: Ocular Hypertension;   Glaucoma;   Open-Angle Glaucoma
Interventions: Drug: i. Fixed combination of latanoprost 0.005% and timolol 0.5%;   Drug: timolol 0.5% ophthalmic solution;   Drug: latanoprost 0.005% ophthalmic solution
5 Recruiting Interaction Study of Timolol Eye Drops and Paroxetine Capsules
Condition: Healthy
Interventions: Drug: Paroxetine;   Drug: Placebo;   Drug: timolol maleate;   Drug: timolol maleate
6 Completed Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination;   Drug: dorzolamide hcl 2%/timolol maleate 0.5% fixed combination;   Drug: brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy;   Drug: dorzolamide hcl 2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy
7 Completed Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination;   Drug: dorzolamide hcl 2%/ timolol maleate 0.5% fixed combination;   Drug: brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy.;   Drug: dorzolamide hcl 2%/timolol maleate 0.5% fixed combinatin as adjunctive to current prostaglandin therapy.
8 Completed 24-Hour Intraocular Pressure (IOP) Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-Angle Glaucoma
Condition: Open-Angle Glaucoma
Interventions: Drug: Drug: dorzolamide/timolol;   Drug: Drug: latanoprost/timolol;   Drug: dorzolamide/timolol and latanoprost;   Drug: placebo (artificial tears)
9 Not yet recruiting Travoprost 0.004%/Timolol 0.5% Versus Timolol 0.5% in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: Travoprost 0.004%/Timolol 0.5%;   Drug: Timolol 0.5%
10 Completed 24-Hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination
Condition: Glaucoma
Interventions: Drug: Drug: bimatoprost/timolol fixed combination AM or PM;   Drug: Drug: bimatoprost/timolol fixed combination PM
11 Completed A Study of Glaucoma or Ocular Hypertension in Patients Within the United States
Conditions: Ocular Hypertension;   Glaucoma
Interventions: Drug: latanoprost 0.005%;   Drug: fixed combination latanoprost-timolol;   Drug: timolol 0.5%
12 Active, not recruiting Comparison of Latanoprost Vs. Timolol
Condition: Glaucoma
Interventions: Drug: Latanoprost;   Drug: Timolol
13 Completed Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: MK0507A, dorzolamide hydrochloride (+) timolol maleate;   Drug: Comparator: timolol maleate;   Drug: Duration of Treatment: Part 1) 6 wk timolol maleate run in;   Drug: Part 2) 6 wk washout pd Part 3) two 8 wk active tx pds
14 Recruiting Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: Fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution;   Drug: timolol maleate 0.5%
15 Completed Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-Forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension.
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: BETOPTIC S (betaxolol HCl);   Drug: Timolol Gel-forming Solution (timolol maleate)
16 Completed Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: Brimonidine 0.2%/Timolol 0.5% Fixed Combination Ophthalmic Solution;   Drug: Concurrent brimonidine 0.2% and 0.5% timolol
17 Completed Travatan Versus Timoptic in Treating Open-Angle Glaucoma or Ocular Hypertension
Condition: Glaucoma
Interventions: Drug: Travoprost 0.004% Ophthalmic Solution (Travatan);   Drug: Timolol 0.5% Ophthalmic Solution (Timoptic)
18 Completed A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: dorzolamide hydrochloride (+) timolol maleate;   Drug: Comparator: dorzolamide HCl/timolol maleate + prostaglandin
19 Completed Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: 0.2% brimonidine/0.5% timolol fixed combination ophthalmic solution;   Drug: Concurrent brimonidine 0.2% and Timolol 0.5% ophthalmic solution;   Drug: Brimonidine 0.2% ophthalmic solution
20 Active, not recruiting The International Collaborative Exfoliation Syndrome Treatment Study
Conditions: Exfoliation Syndrome;   Glaucoma;   Ocular Hypertension
Intervention: Drug: Latanoprost with Pilocarpine vs Timolol or Cosopt

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services